Skip to main content

Advertisement

Table 1 Patient characteristics

From: Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: a randomized, controlled trial

  Sex FEV1 (%) Age (yrs) BMI LTOT Comorbidities Drug sequence
1 M 35.5 59 31 HT, CAD, DM, LPR NaCl, morphine
2 M 29.2 73 14 PAF, Anemia Morphine, NaCl
3 M 29.7 59 23 HT Morphine, NaCl
4 M 22.2 63 32 Yes HT, DM Morphine, NaCl
5 M 24.2 83 16 HT, CAD Morphine, NaCl
6 M 28.7 62 26 TR, MR, OSA NaCl, morphine
7 M 17.4 60 25 NaCl, morphine
8 M 28.6 74 23 NaCl, morphine
9 F 28.0 72 27 Yes HT Morphine, NaCl
10 F 31.0 67 30 Yes GERD NaCl, morphine
Mean 27.5% 67.2 24.7